ClinConnect ClinConnect Logo
Search / Trial NCT05785702

Anti-wandering System for People With Intellectual Disability

Launched by THE UNIVERSITY OF HONG KONG · Mar 14, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Gerontechnology Anti Wandering System Intellectual Disability

ClinConnect Summary

This clinical trial is looking at a new anti-wandering system designed to help keep individuals with intellectual disabilities safe in a day activity center and hostel. The main goals are to find out if this system can help care staff respond more quickly to alarms and reduce their workload when monitoring residents. The study will also explore how many alarms are triggered, how many of those alarms are false, and the overall benefits of this system compared to traditional methods of keeping residents safe.

To participate in the trial, residents of the study sites who are able to move around independently are eligible. Care staff who operate the system can also take part. If you or someone you know is interested, the trial is currently recruiting participants. Throughout the study, participants can expect to be monitored while using the anti-wandering system, and their experiences will help determine how effective this technology is in enhancing safety and support.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Inclusion criteria of residents:
  • • Residents of the study sites
  • Inclusion criteria of care staff:
  • • Responsible for the operation of the anti-wandering system
  • Exclusion Criteria:
  • Exclusion criteria of residents:
  • • Not independently mobile (i.e. unable to walk around without care staff assistance)
  • Exclusion criteria of care staff:
  • • Nil

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Yee Tak Cheung, PhD

Principal Investigator

The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials